BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20142632)

  • 21. Corticotrophin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and pseudo-Cushing state: a comparative study.
    Tirabassi G; Papa R; Faloia E; Boscaro M; Arnaldi G
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):666-72. PubMed ID: 21554373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of non-invasive dynamic tests in the diagnosis of Cushing's syndrome.
    Vilar L; Freitas MC; Naves LA; Canadas V; Albuquerque JL; Botelho CA; Egito CS; Arruda MJ; Silva LM; Arahata CM; Agra R; Lima LH; Azevedo M; Casulari LA
    J Endocrinol Invest; 2008 Nov; 31(11):1008-13. PubMed ID: 19169058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing's disease.
    Losa M; Bianchi R; Barzaghi R; Giovanelli M; Mortini P
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3322-8. PubMed ID: 19584185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticotrophin-releasing activity of desmopressin in Cushing's disease: lack of correlation between in vivo and in vitro responsiveness.
    Pecori Giraldi F; Marini E; Torchiana E; Mortini P; Dubini A; Cavagnini F
    J Endocrinol; 2003 Jun; 177(3):373-9. PubMed ID: 12773117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-invasive Diagnostic Strategy in ACTH-dependent Cushing's Syndrome.
    Frete C; Corcuff JB; Kuhn E; Salenave S; Gaye D; Young J; Chanson P; Tabarin A
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32594169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the DDAVP test in the diagnosis of Cushing's Disease.
    Rollin GA; Costenaro F; Gerchman F; Rodrigues TC; Czepielewski MA
    Clin Endocrinol (Oxf); 2015 Jun; 82(6):793-800. PubMed ID: 25376361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ACTH and cortisol release following intravenous desmopressin: a dose-response study.
    Scott LV; Medbak S; Dinan TG
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):653-8. PubMed ID: 10594528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline and CRH-stimulated ACTH and cortisol levels after administration of the peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone, in Cushing's disease.
    Cannavò S; Ambrosi B; Chiodini I; Vigo T; Russo A; Milici C; Barbetta L; Dall'Asta C; Adda G; Arosio M
    J Endocrinol Invest; 2004 May; 27(5):RC8-11. PubMed ID: 15279069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Desmopressin stimulation test for diagnosis of ACTH-dependent Cushing's syndrome.
    Sakai Y; Horiba N; Tozawa F; Sakai K; Kuwayama A; Demura H; Suda T
    Endocr J; 1997 Oct; 44(5):687-95. PubMed ID: 9466324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second-line tests in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    Barbot M; Trementino L; Zilio M; Ceccato F; Albiger N; Daniele A; Frigo AC; Mardari R; Rolma G; Boscaro M; Arnaldi G; Scaroni C
    Pituitary; 2016 Oct; 19(5):488-95. PubMed ID: 27236452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desmopressin and low-dose ACTH test in rheumatoid arthritis.
    Foppiani L; Cutolo M; Sessarego P; Sulli A; Prete C; Seriolo B; Giusti M
    Eur J Endocrinol; 1998 Mar; 138(3):294-301. PubMed ID: 9539304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6).
    Correa-Silva SR; Nascif SO; Molica P; Sá LB; Vieira JG; Lengyel AM
    Clin Endocrinol (Oxf); 2010 Jan; 72(1):70-5. PubMed ID: 19453623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Desmopressin test in the diagnosis and follow-up of cyclical Cushing's disease.
    Leal-Cerro A; Martín-Rodríguez JF; Ibáñez-Costa A; Madrazo-Atutxa A; Venegas-Moreno E; León-Justel A; García-Hernández N; Luque RM; Castaño JP; Cano DA; Soto-Moreno A
    Endocrinol Nutr; 2014 Feb; 61(2):69-76. PubMed ID: 24183946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human Corticotropin-Releasing Hormone Tests: 10 Years of Real-Life Experience in Pituitary and Adrenal Disease.
    Ceccato F; Tizianel I; Vedolin CK; Boscaro M; Barbot M; Scaroni C
    J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32818260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.
    Correa-Silva SR; Nascif SO; Lengyel AM
    Pituitary; 2006; 9(2):101-7. PubMed ID: 16832586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of the corticotropin-releasing hormone test to monitor the recovery of patients with Cushing's disease or Cushing's syndrome due to an adrenal adenoma after adenomectomy.
    Hotta MN; Shibasaki T; Suda T; Ling N; Shizume K
    Endocrinol Jpn; 1985 Feb; 32(1):113-25. PubMed ID: 2990881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of atrial natriuretic factor infusion on basal and CRH-stimulated ACTH, cortisol and aldosterone levels in patients with Cushing's or Addison's disease.
    Ambrosi B; Sala C; Bochicchio D; Colombo P; Gazzano G; Fadin C; Morganti A; Faglia G
    Clin Endocrinol (Oxf); 1994 May; 40(5):589-94. PubMed ID: 8013139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GHRP-6 is able to stimulate cortisol and ACTH release in patients with Cushing's disease: comparison with DDAVP.
    Oliveira JH; Vieira JG; Abucham J; Lengyel AM
    J Endocrinol Invest; 2003 Mar; 26(3):230-5. PubMed ID: 12809173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.